Financial results - MEDEXCELA S.R.L.

Financial Summary - Medexcela S.r.l.
Unique identification code: 18993799
Registration number: J34/513/2006
Nace: 8622
Sales - Ron
138.556
Net Profit - Ron
47.296
Employee
3
The most important financial indicators for the company Medexcela S.r.l. - Unique Identification Number 18993799: sales in 2023 was 138.556 euro, registering a net profit of 47.296 euro and having an average number of 3 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Medexcela S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 53.366 60.913 67.766 71.524 78.277 89.160 124.518 134.640 162.032 138.556
Total Income - EUR 58.438 65.648 67.767 71.524 78.281 89.165 124.519 243.798 163.759 144.042
Total Expenses - EUR 25.136 26.032 13.947 18.268 27.535 45.710 57.250 165.491 66.492 95.368
Gross Profit/Loss - EUR 33.301 39.616 53.820 53.256 50.746 43.455 67.270 78.307 97.267 48.673
Net Profit/Loss - EUR 31.700 37.756 52.464 52.517 49.963 42.563 66.114 75.869 95.714 47.296
Employees 2 2 1 1 1 3 3 3 3 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -14.2%, from 162.032 euro in the year 2022, to 138.556 euro in 2023. The Net Profit decreased by -48.128 euro, from 95.714 euro in 2022, to 47.296 in the last year.

Check the financial reports for the company - Medexcela S.r.l.

Rating financiar

Financial Rating -
Medexcela S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Medexcela S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Medexcela S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Medexcela S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Medexcela S.r.l. - CUI 18993799

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 7.227 757 1.106 678 41.871 169.287 198.255 75.400 98.278 86.564
Current Assets 32.265 40.831 54.982 55.215 63.641 49.895 55.313 184.299 82.079 18.935
Inventories 0 0 0 0 387 36.214 381 0 0 0
Receivables 2.589 2.013 2.113 5.640 4.280 298 41.742 170.265 78.651 6.975
Cash 29.676 38.818 52.869 49.576 58.974 13.383 13.190 14.033 3.429 11.960
Shareholders Funds 34.770 40.851 55.551 55.551 104.495 145.034 249.746 119.392 139.385 100.032
Social Capital 45 45 67 66 64 63 62 61 61 61
Debts 4.722 737 537 343 1.017 74.148 3.822 140.307 40.973 5.467
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 18.935 euro in 2023 which includes Inventories of 0 euro, Receivables of 6.975 euro and cash availability of 11.960 euro.
The company's Equity was valued at 100.032 euro, while total Liabilities amounted to 5.467 euro. Equity decreased by -38.930 euro, from 139.385 euro in 2022, to 100.032 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Medexcela S.r.l.

Comments - Medexcela S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.